Budget cuts, delays to grant reviews, and layoffs of federal workers at agencies like the NIH and the National Science Foundation have affected nearly every research organization in the US. If ...

Parents will participate in late April with Reverse Rett 2025 to raise funds to battle syndrome afflicting their daughter.

Fintel reports that on March 31, 2025, RBC Capital downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from ...

Setting a New Benchmark in Precision and Efficiency for LNP Analysis SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 31, 2025 ...

The sudden departure of Peter Marks, MD, from the FDA has prompted a chorus of criticism and despair from industry leaders and trade organizations.

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug ...

Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.

While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

Single-Molecule Footprinting reveals that RNA polymerase II (Pol II) occupancy is infrequent at mouse promoters. This results ...

Drugs from Novartis, Amgen and now Lilly have proven powerfully effective at reducing Lp(a). Whether that will translate to a ...

Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced the appointment of Joseph Bolen, Ph.D., as Chief ...